Rhoh is a hematopoietic system-specific GTPase. Rhoh-deficient T cells have been shown to have a defect in TCR signaling manifested during their thymic development. Our aims were to investigate the phenotype of peripheral Rhoh-deficient T cells and to explore in vivo the potential benefit of Rhoh deficiency in a clinically relevant situation, in which T-cell inhibition is desirable. In murine allogenic kidney transplantation, Rhoh deficiency caused a significant 75% reduction of acute and chronic transplant rejection accompanied by 75% lower alloantigen-specific antibody levels and significantly better graft function. This effect was independent of the lower T-cell numbers in Rhoh-deficient recipients, because injection of equal numbers of Rhoh-deficient or control T cells into kidney transplanted mice with SCID led again to a significant 60% reduction of rejection. Mixed lymphocyte reaction revealed that the weaker alloreactivity was associated with a 85% lower cytotoxicity and a 50-80% lower cytokine release in Rhoh-deficient T cells without an influence on the secretion itself. Antigen uptake and presentation in DC were unaffected by Rhoh deficiency. These findings stress the importance of Rhoh for the function of peripheral T cells.Key words: Animal models . T cell . Transplantation
IntroductionRas homolog gene family, member H (Rhoh) (previous name: translocation three four) is a member of the large family of the small monomeric GTPases, which are intracellular plasma membrane-bound signaling molecules, exerting regulatory functions in a wide variety of cellular processes such as cytoskeleton organization, cell polarization, vesicle formation and transport as well as proliferation. These intracellular switches cycle between two functional states: in the active state (GTP bound), they are able to interact with downstream effector molecules and thus generate a response until their intrinsic GTPase activity hydrolyzes the bound GTP and thereby returns them into an inactive (GDP bound) state. The group of small monomeric GTPases encompasses five major families: Arf, Rab, Ran, Ras and Rho (Ras homolog); the latter consisting of Rho-, Rac-and Cdc42-subfamilies [1]. The hematopoietic-specific Rho GTPase, Rhoh, was initially described as a fusion transcript resulting from chromosomal translocation t(3, 4) (hence, the former name ''translocation three four'') in several cases of B-cell diffuse large cell lymphoma and multiple myeloma [2][3][4]. Further investigations confirmed the restriction of Rhoh expression to hematopoiesis-related organs (BM, thymus and spleen) and in particular to hematopoietic progenitor cells as well as fully differentiated myeloid and lymphoid cells [5]. In contrast to most other small à These authors have contributed equally to this study. Although recently a substantial progress has been achieved in the treatment of acute rejection of transplanted organs, the adverse effects of the current immunosuppressive drugs and chronic transplant dysfunction represent unresolved clinical problems. A...